Novavax Inc (NVAX)
8.64
-0.08
(-0.86%)
USD |
NASDAQ |
Dec 23, 10:33
Novavax Cash from Investing (Quarterly): 31.91M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | -2.057B |
| Moderna Inc | 721.00M |
| Inovio Pharmaceuticals Inc | 14.08M |
| Baxter International Inc | -164.00M |
| Halozyme Therapeutics Inc | -167.48M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -144.81M |
| Cash from Financing (Quarterly) | -0.097M |
| Free Cash Flow | -112.35M |
| Free Cash Flow Per Share (Quarterly) | -0.9174 |
| Free Cash Flow to Equity (Quarterly) | -147.24M |
| Free Cash Flow to Firm (Quarterly) | -142.63M |
| Free Cash Flow Yield | -8.82% |